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Abstract
Background-: PedGenie software, introduced in 2006, includes genetic association testing of
cases and controls that may be independent or related (nuclear families or extended pedigrees) or
mixtures thereof using Monte Carlo significance testing. Our aim is to demonstrate that PedGenie,
a unique and flexible analysis tool freely available in Genie 2.4 software, is significantly enhanced by
incorporating meta statistics for detecting genetic association with disease using data across
multiple study groups.
Methods-: Meta statistics (chi-squared tests, odds ratios, and confidence intervals) were
calculated using formal Cochran-Mantel-Haenszel techniques. Simulated data from unrelated
individuals and individuals in families were used to illustrate meta tests and their empirically-derived
p-values and confidence intervals are accurate, precise, and for independent designs match those
provided by standard statistical software.
Results-: PedGenie yields accurate Monte Carlo p-values for meta analysis of data across multiple
studies, based on validation testing using pedigree, nuclear family, and case-control data simulated
under both the null and alternative hypotheses of a genotype-phenotype association.
Conclusion-: PedGenie allows valid combined analysis of data from mixtures of pedigree-based
and case-control resources. Added meta capabilities provide new avenues for association analysis,
including pedigree resources from large consortia and multi-center studies.
Background
In the study of common diseases and genes with modest
effects, large consortium and multi-center efforts hold the
promise of increased power to detect associations, but
present analysis challenges. The study populations for the
multiple centers may differ geographically and ethnically,
and considerable differences in case-control ascertain-
ment and pedigree structures between studies are likely.
PedGenie, available as an analysis option in Genie 2.4
software, requires Java 1.6 for execution and extends the
functionality previously available in PedGenie 1.2 [1] by
incorporating meta statistics for combined analysis of
multi-study resources, along with Monte Carlo signifi-
cance testing which allows for a mixture of pedigree mem-
bers and independent individuals [2]. PedGenie offers a
novel, structured approach that allows valid meta associa-
tion testing, where each study considered can be a mixture
of family-based individuals (including pedigrees of arbi-
Published: 15 November 2007
BMC Bioinformatics 2007, 8:448 doi:10.1186/1471-2105-8-448
Received: 19 July 2007
Accepted: 15 November 2007
This article is available from: http://www.biomedcentral.com/1471-2105/8/448
© 2007 Curtin et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 8
(page number not for citation purposes)
BMC Bioinformatics 2007, 8:448 http://www.biomedcentral.com/1471-2105/8/448trary size and complexity) and singletons, not simply
pooling of data across studies. Briefly, study-specific allele
frequencies for markers of interest are used within studies.
A Mendelian gene-drop is performed in each study sepa-
rately, in accordance with its own allelic characteristics,
independent of trait. Each possible null genotype config-
uration for all studies is used to create a null meta statistic,
which creates an empirical null distribution for the signif-
icance testing when repeated multiple times. These meth-
ods, detailed below, have been previously described for
single studies [2] and applied to existing study data in can-
didate gene association and transmission testing [3].
In addition to offering all the capabilities of version 1.2,
PedGenie (version 2.4) includes allele and genotype asso-
ciation analysis across studies based on formal Cochran-
Mantel-Haenszel (CMH) techniques to calculate the fol-
lowing meta statistics: chi-squared test of independence,
chi-squared test of trend, and odds ratios and confidence
intervals. An illustration of a meta-association analysis as
implemented in PedGenie can be found in Curtin et al
[4]. Here we formally introduce and validate the addition
of these meta association statistics by using simulated
data for independent individuals to illustrate that the
meta tests performed in PedGenie and their associated
empirically-derived p-values and confidence intervals, are
accurate, precise, and match those provided by standard
statistical software. Further, we illustrate the flexibility of
the method with an application with simulated data of
mixed study design- a design that no other software cur-
rently available can address for meta association. Simu-
lated case-control (independent) and family-based
(nuclear and extended pedigree) study data under both a
null hypothesis of no association and an alternate
hypothesis of a genotype-phenotype association were
used.
Implementation
PedGenie is a flexible, easily implemented, and freely
available analysis tool that is enhanced significantly in
Genie 2.4 software [5] by the incorporation of meta statis-
tics to allow valid combined analysis of multiple studies
in the detection of genetic association with common dis-
ease. Java 1.6 is required for execution.
Methods
Meta statistics
In epidemiologic studies, data are often collected that can
be summarized in three-way contingency tables, the pres-
ence or absence of a disease phenotype cross-classified
with allele or genotype, and controlling for a third cate-
gorical variable or 'group' [6]. In a multi-center collabora-
tion, this third factor represents study site. Meta statistics
for a genotypic or an allelic association across studies, cur-
rently incorporated in PedGenie, are based on a multivar-
iate extension of the Cochran-Mantel-Haenszel (CMH)
test to sets of (s × r) contingency tables, indexed by i = 1,
2,..., s and j = 1, 2,..., r in terms of the corresponding mul-
tiple hypergeometric model as formulated in Landis and
Koch [7]. The CMH test is based on a fixed-effects
approach [8], in which PedGenie assumes the same
genetic effect size across studies. The generalized CMH
approach was used to calculate a chi-squared general asso-
ciation test of independence and chi-squared test of trend
(mean score statistic where ordered wildtype, hetero-
zygous, and homozygous variant genotypes lie on an
ordinal scale) [5]. Meta odds ratios in PedGenie were cal-
culated as the Mantel-Haenszel estimate of the common
odds ratio for stratified 2 × 2 tables described in [9,10],
with corresponding 95% confidence limits estimated
empirically, as the 2.5th and 97.5th percentile of odds
ratios from the null genotype configurations.
An outline of steps for meta statistics in PedGenie follows.
First, allele frequencies for the markers of interest are esti-
mated from the data. This is performed separately for each
study. As before, these can be estimated by four different
methods: genotyped founders only, all genotyped indi-
viduals, all founders with statistically inferred genotypes,
and user-defined (for details of each, see [2]). Second,
alleles are assigned to the pedigree founders randomly,
but in proportion to the study-specific allele frequencies,
and a Mendelian gene-drop is performed. That is, the
gene-drop is performed independently of trait informa-
tion. The resulting null genotype configuration across all
pedigrees and singletons, therefore represents a possible
configuration under the null hypothesis of no association
between allele and disease, maintaining study-specific
allele frequencies. Third, the meta statistic of interest is
calculated using the null genotype configuration and the
true phenotype data, maintaining the study identities but
ignoring the pedigree relationships that exist, which we
term Mi. The Mi meta statistic is from the null distribution
since it was derived from data simulated under the null
hypothesis. To match the information content of the real
data, we limit calculation of the statistic of interest in the
simulated data to only those individuals with genotype
data in the observed sample. In this way, the missing data
structure is captured. Steps 2 and 3 are repeated multiple
(N) times, and the series of null meta statistics stored.
Hence an empirical null distribution is created for the
meta statistic of interest, conditional on the particular
pedigree and phenotype structures contained across all
studies in the total resource.
Finally, the observed statistic, M0, is computed based on
the true genotype and phenotype data using the same
meta statistic of interest, again ignoring any pedigree rela-
tionships that exist. This observed meta statistic is thenPage 2 of 8
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significance as follows:
The specified null hypothesis is rejected if the p-value is
less than or equal to the required level of type I error (α).
Monte Carlo p-value and confidence interval assessment
To evaluate the accuracy of the meta association statistics
available in PedGenie (CMH chi-square, CMH trend,
meta ORs) and corresponding empirical p-values and
95% confidence intervals (95% CI), two simulated meta-
datasets were constructed, each comprised of three stud-
ies, as described below. Briefly, two test set designs were
used. The first 'independent' design was comprised of
three separate studies of varying sample size, each being
the standard association design of independent cases and
1:1 frequency matched controls. Results from this design
should be in exact agreement with results from standard
statistical packages for test statistics, and in asymptotic
agreement for their associated p-values and confidence
intervals. The second 'mixed' design was comprised of
mixtures of study designs (independent and family-
based), both within and between studies. This 'mixed'
design is used to illustrate PedGenie's versatility.
Within each of the two meta-analytic datasets (independ-
ent or mixed design), a variety of sample sizes and minor
allele frequencies (MAFs) for one bi-allelic single nucle-
otide polymorphism (SNP) were used across the compo-
nent studies as detailed in the following section. In each
component study, a dataset was simulated under two sce-
narios: one under the null hypothesis of no association,
and another under the alternative hypothesis of associa-
tion of an allele of interest and phenotype. Under the null
scenario, a sporadic rate of 0.10 for affected phenotype
status was randomly assigned, regardless of genotype.
Under the alternate scenario, penetrances for each geno-
type (AA, Aa, and aa, where A is the common allele) were
determined based on a multiplicative genetic model with
a genotypic relative risk (GRR) of 1.5 and a sporadic rate
of 0.10, according to the methodology described in Camp
[11].
Since PedGenie is an empirical approach, we repeated this
procedure 1,000 times for each test design (independent
or mixed) and scenario (null or alternative) by randomly
re-seeding the initial assignment of alleles in each analysis
to demonstrates the reproducibility of the Monte Carlo
method, as equivalent results are obtained if a different
random number seed is used. The means and standard
deviations of the 1,000 empirical p-values and confidence
intervals for each meta study simulation were examined
for stability and accuracy. For the 'independent' test
design, the meta statistics and p-values were compared to
statistics and p-values from a standard distribution using
an established statistical software package (SAS® version
9.1). For each PedGenie analysis, either 1,000 configura-
tions (for the null scenario) or 10,000 configurations (for
the alternate scenario) were used to determine the empir-
ical null distribution and p-values and confidence inter-
vals for meta (across studies) and within-study test
statistics. Generally, the number of gene-dropping config-
urations was guided by the expected size and desired pre-
cision of a p-value. Clearly, the accuracy of the empirical
p-value increases with the size of the empirical null distri-
bution simulated; for example, an N of 2,000 gives a 95%
confidence interval around α = 0.05 with a width of 0.02
under the null hypothesis.
Methods to generate meta-analytic datasets
Independent design
Three separate studies of independent cases and randomly
selected, frequency-matched controls (1:1 ratio) were sim-
ulated with the following sample sizes and MAFs: 1,000
independent cases and 1,000 random controls, MAF =
0.05 (study 1.1); 500 independent cases and 500 random
controls, MAF = 0.10 (study 1.2); and 250 independent
cases and 250 random controls, MAF = 0.20 (study 1.3).
Data were constructed for this design under both the null
and alternative scenarios as described above.
Mixed design
Three separate studies with a mixture of both family-
based and independent resources were simulated with the
following sample sizes and MAFs: 1,000 independent
cases and 1,000 random controls, MAF = 0.05 (study 2.1,
which is equivalent to study 1.1); nuclear families consist-
ing of 200 affected sib-pairs plus parents, 200 discordant
sib-pairs plus parents, and 200 independent controls,
MAF = 0.10 (study 2.2); and four-generation pedigrees
consisting of 53 family members per pedigree (sibships of
size three in all generations, and all sibs marry in genera-
tions 2 and 3); and including 500 independent controls,
MAF = 0.20 (study 2.3).
Study characteristics resulting from the independent and
mixed design simulations under the null and alternative
scenarios are shown in Tables 1 and 2, respectively. To
construct case-control studies 1.1 (also called 2.1), 1.2,
and 1.3, large "source" populations were simulated. First,
alleles were assigned to independent individuals in three
"populations" of over 10,000 individuals based on the
specified MAF for each study. Second, phenotype status
was assigned to individuals randomly, but according to
the appropriate penetrances under the either the null or
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simulated "source" population.
For the nuclear family study (study 2.2), alleles were first
randomly assigned to parents in families with two siblings
in a "population" of over 15,000 families (four individu-
als per pedigree) based on the specified MAF. Second, alle-
les were assigned to siblings according to Mendelian
inheritance. Third, phenotype was assigned to all individ-
uals randomly, but according to penetrances under either
the null or alternate scenario. Finally, 400 nuclear families
(200 affected and 200 discordant sib-pairs and their par-
ents) were selected randomly from the "source" popula-
tion. In addition, 200 independent controls were
randomly selected from case-control study 1.2 from the
appropriate scenario (null or alternate) to create study
2.2, a mixed family and independent resource. Genotypes
on all parents, affected and unaffected, were also included
in the simulation to demonstrate the flexibility of PedGe-
nie to handle any pedigree structure and use all informa-
tion available in each pedigree. This resulted in additional
family-based cases and controls as noted in Tables 1 and
2.
Similarly, in extended family study (study 2.3), the initial
step consisted of randomly assigning alleles to all found-
ers in a "population" of 150 four-generation pedigrees (14
founders and 53 members per pedigree) based on the
MAF specified previously. Second, a Mendelian gene-drop
was performed in which alleles were assigned to offspring
Table 2: Simulated study characteristics, alternate scenario.
Study Description Pop. MAF Sample size (N) Study cases Study controls
Total Cases Ctrls. MAF AA Aa aa MAF AA Aa aa
Independent design meta-analytic datasets
1.1 Case-control 0.05 2000 1000 1000 0.07 865 130 5 0.05 906 92 2
1.2 Case-control 0.10 1000 500 500 0.13 375 116 9 0.09 413 83 4
1.3 Case-control 0.20 500 250 250 0.26 136 96 18 0.19 163 80 7
Mixed design meta-analytic datasets
2.1 Case-control 0.05 2000 1000 1000 0.07 865 130 5 0.05 906 92 2
2.2 Nuclear families and independents1 0.10 1800 694 1106 0.16 496 180 18 0.12 853 242 11
2.3 Pedigrees and independents2 0.20 4190 503 3687 0.23 294 184 25 0.19 2386 1184 117
1400 affected sibs in ASPs, 200 affected sibs in DSPs, and 94 family cases; 200 unaffected sibs in DSPs, 706 family, and 200 independent controls.
2503 family cases and 3,187 family controls in 83 four-generation pedigrees (founders and first generation ungenotyped), 500 independent controls.
Table 1: Simulated study characteristics, null scenario.
Study Description Pop. MAF Sample size (N) Study cases Study controls
Total Cases Ctrls. MAF AA Aa aa MAF AA Aa aa
Independent design meta-analytic datasets
1.1 Case-control 0.05 2000 1000 1000 0.06 892 105 3 0.05 898 100 2
1.2 Case-control 0.10 1000 500 500 0.10 404 91 5 0.10 409 86 5
1.3 Case-control 0.20 500 250 250 0.19 162 79 9 0.21 156 84 10
Mixed design meta-analytic datasets
2.1 Case-control 0.05 2000 1000 1000 0.06 892 105 3 0.05 898 100 2
2.2 Nuclear families and independents1 0.10 1800 675 1125 0.10 546 120 9 0.10 915 196 14
2.3 Pedigrees and independents2 0.20 4550 501 4049 0.19 333 147 21 0.20 2584 1279 186
1400 affected sibs in affected sib-pairs (ASPs), 200 affected sibs in discordant sib-pairs (DSPs), and 75 family cases; 200 unaffected sibs in DSPs, 725 
family, and 200 independent controls.
2501 family cases and 3,549 family controls in 90 four-generation pedigrees (founders and first generation ungenotyped), 500 independent controls.Page 4 of 8
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assigned to individuals randomly, but according to pene-
trances under the either the null or alternate scenario.
Genotype data for generations 1 and 2 were removed,
such that genotypes were only considered available for the
bottom two generations. Finally, pedigrees containing at
least four related, genotyped cases were randomly selected
until ~500 affected family members had been ascertained.
This resulted in 90 pedigrees in the null scenario, and 83
pedigrees in the alternate scenario containing 501 and
503 family-based cases, respectively. In addition, 500
unaffected independent controls were randomly selected
from a source "population" corresponding to the null or
alternate scenario samples in case-control Study 1.3 to cre-
ate a mixed pedigree and independent resource. All family
members with genotypes, both affected and unaffected,
were included in the simulation to demonstrate the flexi-
bility of PedGenie to handle large pedigree structures and
use all information available in each pedigree. This flexi-
bility resulted in additional pedigree-based controls as
detailed in Tables 1 and 2.
Results
The Monte Carlo p-value and confidence interval assess-
ment results, for 1,000 randomly seeded runs using the
multi-study, independent-design meta-analytic datasets
under both null and alternate scenarios, are shown in
Tables 3 and 4, respectively. Likewise, the p-value and
confidence interval assessment results, for 1,000 ran-
domly seeded runs using the mixed-design meta-analytic
datasets (null and alternate scenarios), are shown in
Tables 5 and 6, respectively. In each run, repeated 1,000
times using a different random number seed, statistics and
empirical p-values or 95% confidence intervals (CIs) were
derived according to the methods in PedGenie from 1,000
null distribution configurations (null scenario), and
10,000 null configurations (alternate scenario). The statis-
tics, mean (and standard deviation) for p-values and 95%
CIs were compared to the corresponding meta statistics,
standard p-values, and standard 95% CIs from established
statistical software for the independent design (Tables 3
and 4).
For the independent design, all statistics were shown to be
equivalent to those from a standard package (Tables 3 and
4). The p-values from 1,000 randomly seeded runs of
PedGenie were tightly and normally distributed based on
their mean and standard deviation. The corresponding
median p-values and interquartile ranges were in very
close agreement (data not shown). In the alternate sce-
nario, where p-values were much smaller than in the null
scenario, the majority of p-values were within 0.0001 of
the value from the standard distribution (Table 4), and
none were significantly different from expected based on
the standard distribution.
The PedGenie software implements a Monte Carlo
approach that corrects the null distribution, and not the
observed statistic, for family relationships and hence the
statistics for the mixed design are also the standard statis-
tics. As shown in Tables 5 and 6, these match precisely.
However the p-values and 95% CIs for the mixed design
incorporate the relatedness of individuals and thus cannot
be compared to results from standard statistical packages.
To illustrate performance, runtime is reported. Runtime
for PedGenie (null scenario) with 1,000 null configura-
tions took approximately 1 minute, 30 seconds per single
independent-design meta analysis and under 4 minutes
per single mixed-design meta analysis on a Dell® Precision
670 computer with 4 gigabytes of memory, using a Red
Hat® linux operating system. Runtime (alternate scenario)
Table 3: Independent design meta analysis of case-control studies, 1 null scenario. 2
Description CMH Chi Square CMH Chi-Square Trend Meta Odds Ratio
Aa vs. AA aa vs. AA
Statistic, PedGenie 2.1 0.06 0.05 1.02 0.99
Empirical p-value, mean (SD) 0.970 (0.005) 0.829 (0.012) 0.818 (0.031) 0.967 (0.028)
Empirical 95% CI: lower (SD) 0.85 (0.007) 0.49 (0.016)
Empirical 95% CI: upper (SD) 1.24 (0.010) 2.00 (0.068)
Statistic, SAS® 0.06 0.05 1.02 0.99
Standard p-value 0.972 0.830 0.816 0.971
Standard 95% CI: lower 0.85 0.50
Standard 95% CI: upper 1.23 1.96
1Studies 1.1, 1.2, and 1.3.
21,000 configurations in the PedGenie null.Page 5 of 8
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minutes per independent-design meta analysis and ~35
minutes per mixed-design meta analysis.
Discussion
For common traits involving small effect genes, consortia
and multi-center efforts are becoming commonplace. For
example, CMH statistics for ordered genotypes have been
used to assess association in multiple case-control studies
in which cases are independent, either as probands or as
randomly selected affecteds [12]. Complex statistical
issues arise when study designs vary across groups who
wish to combine data; currently, only a limited number of
approaches exist to address this. A combined odds ratio/
relative risk estimate of association in both case-control
and transmission-disequilibrium test (TDT) studies has
been proposed [13,14]. Strategies for combining evidence
in case-control and nuclear families have also been devel-
oped [15-17] and one package, Pseudomarker, can also
include extended pedigrees [18]. However, one or more
limitations exist in these other software: only single point
analyses are available; limited pedigree structures can be
incorporated; and/or there exists an implicit assumption
that the component studies of the mixed designs are ascer-
tained from the same source population and are therefore
not robust to marker allele frequency differences across
studies. PedGenie allows for valid meta analyses of com-
bined family-based and case-control data, both within
and between studies, using CMH techniques. The tests are
robust to marker allele frequency difference across studies
because separate gene-drops using study-specific frequen-
cies are used in the Monte Carlo simulations. PedGenie
can accommodate comprehensive information in large
and complex multi-generational families without pedi-
gree splitting or dropping of individuals required in other
packages [19-21], with acceptable processing times.
PedGenie can incorporate all relationships in family-
based resources, therefore all family members with phe-
notype and genotype data that are available can be
included. For example, if only one affected sibling was
chosen from each pedigree as some investigators are
forced to do to appropriately utilize standard statistical
packages, the sample size in study 2.2 would have been
reduced under the alternate scenario from 694 cases, 200
independent controls, and 706 family-based controls to
Table 5: Mixed design meta analysis of case-control and family-based/mixed-resource studies, 1 null scenario. 2
Description CMH Chi Square CMH Chi-Square Trend Meta Odds Ratio
Aa vs. AA aa vs. AA
Statistic, PedGenie 2.1 0.23 0.22 0.97 0.94
Empirical p-value, mean (SD) 0.886 (0.010) 0.616 (0.016) 0.630 (0.029) 0.786 (0.030)
Empirical 95% CI: lower (SD) 0.85 (0.005) 0.60 (0.013)
Empirical 95% CI: upper (SD) 1.10 (0.006) 1.48 (0.032)
Statistic, SAS® 0.23 0.22 0.97 0.94
1Studies 2.1, 2.2, and 2.3.
21,000 configurations in the PedGenie null.
3P-values and 95% CIs are not given as SAS cannot account for dependent relationships, and hence are not appropriate.
Table 4: Independent design meta analysis of case-control studies, 1 alternate scenario. 2
Description CMH Chi Square CMH Chi-Square Trend Meta Odds Ratio
Aa vs. AA aa vs. AA
Statistic, PedGenie 2.1 26.49 26.17 1.49 2.81
Empirical p-value, mean (SD) <0.0001 (<0.0001) <0.0001 (<0.0001) <0.0001 (<0.0001) 0.0020 (0.0006)
Empirical 95% CI: lower (SD) 1.24(0.0031) 1.51 (0.0136)
Empirical 95% CI: upper (SD) 1.79 (0.0044) 5.24 (0.0475)
Statistic, SAS® 26.49 26.17 1.49 2.81
Standard p-value <0.0001 <0.0001 <0.0001 0.0014
Standard 95% CI: lower 1.24 1.45
Standard 95% CI: upper 1.79 5.42
1Studies 1.1, 1.2, and 1.3.
210,000 configurations in the PedGenie null.Page 6 of 8
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useful for linkage consortia interested in pursuing associ-
ation testing, as PedGenie can provide valid meta analyses
across multiple studies each containing family-based
cases and family-based controls, in addition to any sup-
plemental independent controls available. The ability to
more fully utilize all data on hand both increases the util-
ity of prior linkage resources and provides increased
power to detect associations, particularly in stratified and
subset analyses that likely lead to small sample sizes in
individual studies. We anticipate that the new meta capa-
bilities in PedGenie will provide new avenues for linkage
consortia to explore in terms of association testing.
A potential limitation of PedGenie meta analysis is the
fixed-effects nature of the CMH approach, and interpreta-
tion of the meta odds ratio is dependent on an assump-
tion of homogeneity in genetic effects across studies.
Future work will include providing an option to test for
heterogeneity across studies such as described in
[8,22,23], and developing a random-effects model exten-
sion allowing for heterogeneity such as that recently pro-
posed by Bagos and Nikolopoulos based on logistic
regression [24]. When heterogeneity is not extreme, it has
been shown that fixed- and random-effects models yield
similar results [8]. However, use of a random-effects
model does not control or adjust for heterogeneity, and
choice of a fixed- or random-effects model should be sec-
ondary to examination of factors contributing to hetero-
geneity [8].
In this study, we have described allele and genotype tests
for single SNPs. PedGenie also incorporates haplotype
and composite genotype tests; these are based on the most
likely haplotype configurations from expectation-maxi-
mization (both in the observed and all simulated data)
rather than a full likelihood approach based on all possi-
ble haplotypes (which is not a feasible approach for ped-
igrees of arbitrary size). We are currently working towards
more sophisticated haplotype methods. Future efforts will
also include meta extensions for other quantitative and
transmission statistics, such as the TDT test, and multiple
logistic regression analysis (including a random-effects
extension) with covariates.
Conclusion
We have demonstrated PedGenie is a valid statistical soft-
ware tool that offers a comprehensive way of performing
valid meta association testing across studies of mixed
design. PedGenie (freely available in Genie 2.4 software)
can accommodate independent and family-based
resources, allowing for more power to detect associations
by allowing for valid combined analyses and maximal use
of available data.
Availability and Requirements
PedGenie is an analysis option in Genie 2.4 software, Uni-
versity of Utah Genetic Epidemiology Division, freely
available at http://www-genepi.med.utah.edu/Genie/
index.html[5]. Java 1.6 is required for execution, along
with the following files: Genie.jar (downloaded in
Genie.zip), a parameter file (user-defined .rgen, XML file;
go to ".rgen Parameter File" link from the Genie home
page for detailed description and examples), and user-
provided genotype data file(s) in pedigree format (there is
no restriction on the number of files). For a description of
functionality and instructions for execution, see "PedGe-
nie" page; select "PedGenie Examples" and "Meta/CMH
Analysis Example" for examples of meta statistical analy-
sis input and output files.
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